Jan Degenhardt

• Define & execute global product strategy for digital research applications within Carl ZEISS Meditec • Coordinate product development and go-to-market for research apps and platform

• Coordinate strategy execution of MedTech unit in a key country for ZEISS including the definition and piloting of engine for business innovation projects • Lead data analytics workstream as part of larger operational excellence project to facilitate company transformation • Lead pricing and monetization pilot for innovative MedTech device including the definition of company-wide project blueprint

• Lead commercial due diligence workstream for M&A projects with deal volume up to €50mn+ • Run 5+ industry studies supporting market entry decisions • Lead rollout of OKR (Objectives & Key Results) within company (30k+ employees)

• Development of mass spectrometry-based assay addressing issue having annual €100k+ profit impact for brewing industry client •Development of protein quantification assay significantly outperforming industry status-quo • Optimization of analytical sample preparation methods for proteomics workflow

• Support business development initiatives with market & technology research of medical technology and pharmacy markets • Definition of a strategic vision on trends in robotics • Support implementation of best-practice service platform

• Characterization of DNA structure with 2D-NMR • Syntheses of DNA to enable research on cancer prevention • Analysis of human gut microbiota to identify drug-related changes

Major: Technology management/SCM and Analytical chemistry Master Thesis: Quantification of Proteinase A in beer using mass spectrometry methods

Major: Physical Chemistry Bachelor-Thesis: Femtosecond time-resolved fluorescence upconversion spectroscopy of potential ESIPT switches